Mitchel S. Berger
- Genetics top 0.01%
- Epidemiology top 0.05%
- Radiology, Nuclear Medicine and Imaging top 0.02%
- Molecular Biology top 0.2%
- Neurology top 0.05%
- Co-authors
- Nader SanaiSusan M. ChangAndrew T. ParsaMichael W. McDermottGeorge A. OjemannEdward F. ChangShawn L. Hervey‐JumperKathleen R. Lamborn
- Topics
- Glioma Diagnosis and Treatment (404 papers)Meningioma and schwannoma management (176 papers)Brain Metastases and Treatment (71 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Mitchel S. Berger
695 papers receiving 50.2k citations
Hit Papers
Peers
Comparison fields: 5 of 194
- Genetics 23.6k
- Epidemiology 11.5k
- Radiology, Nuclear Medicine and Imaging 11.1k
- Molecular Biology 10.9k
- Neurology 7.6k
Countries citing papers authored by Mitchel S. Berger
This map shows the geographic impact of Mitchel S. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchel S. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchel S. Berger more than expected).
Fields of papers citing papers by Mitchel S. Berger
This network shows the impact of papers produced by Mitchel S. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchel S. Berger. The network helps show where Mitchel S. Berger may publish in the future.
Co-authorship network of co-authors of Mitchel S. Berger
This figure shows the co-authorship network connecting the top 25 collaborators of Mitchel S. Berger. A scholar is included among the top collaborators of Mitchel S. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchel S. Berger. Mitchel S. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 42 | |
| 6 | 32 | |
| 7 | 28 | |
| 8 | 32 | |
| 9 | 28 | |
| 10 | 15 | |
| 11 | 33 | |
| 12 | 33 | |
| 13 | 23 | |
| 14 | 150 | |
| 15 | 185 | |
| 16 | 34 | |
| 17 | 42 | |
| 18 | Functional Outcome after Language Mapping for Glioma Resectionbreakdown → | 748 |
| 19 | 23 | |
| 20 | 435 |
About Mitchel S. Berger
Mitchel S. Berger is a scholar working on Genetics, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 718 papers that have together received 51.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (404 papers), Meningioma and schwannoma management (176 papers) and Brain Metastases and Treatment (71 papers). The work is most often cited by research in Genetics (23.6k citations), Developmental Neuroscience (2.8k citations) and Neurology (7.6k citations). Mitchel S. Berger has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Nader Sanai, Susan M. Chang, Andrew T. Parsa, Michael W. McDermott, George A. Ojemann, Edward F. Chang, Shawn L. Hervey‐Jumper, Kathleen R. Lamborn, Ettore Lettich and Michael D. Prados. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.